Literature DB >> 3110066

Serotype specificity and immunogenicity of the capsular polymer of Haemophilus pleuropneumoniae serotype 5.

T J Inzana, B Mathison.   

Abstract

Serotyping of Haemophilus pleuropneumoniae and serologic assays for detection of serotype-specific antibody are problematic due to the potential cross-reactivity of the crude antigens used for raising immune serum or for serology. The capsular polymer (CP) of H. pleuropneumoniae serotype 5 was investigated for serotype-specific activity with antiserum to whole cells or with antiserum made monospecific to CP by adsorption with a capsule-deficient mutant. When antiserum to whole cells or monospecific antiserum to CP was tested against purified CP from serotypes 1 to 7 by immunodiffusion or enzyme-linked immunosorbent assay, only capsules of serotype 5 were reactive. In addition, only encapsulated serotype 5 cells reacted with serum monospecific to CP in an indirect immunofluorescent-antibody assay. Serotype-specific antibody was completely inhibited in each assay by preincubation of purified CP with the serum. Antiserum to whole cells of H. pleuropneumoniae serotype 5 contained antibodies to proteins and lipopolysaccharide; these antibodies cross-reacted with antigens of heterologous serotypes by dot-blot enzyme-linked immunosorbent assay and immunoblotting. The antigenic activity of CP was stable after heating for at least 30 min at 100 degrees C. High titers of antibody to CP were present in the sera of rabbits immunized intravenously with whole log-phase cells or in the convalescent sera of pigs experimentally infected with H. pleuropneumoniae serotype 5. However, the purified CP was poorly immunogenic in rabbits and swine. Our results indicate that the capsule is the serotype-specific antigen of H. pleuropneumoniae and that a monospecific antiserum to capsule or purified capsule should be used for serotyping or serologic assays, respectively.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3110066      PMCID: PMC260561          DOI: 10.1128/iai.55.7.1580-1587.1987

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  28 in total

1.  Isolation of the capsular polysaccharide from culture supernatant of Haemophilus influenzae type b.

Authors:  P Anderson; D H Smith
Journal:  Infect Immun       Date:  1977-02       Impact factor: 3.441

2.  Outer membrane protein profiles of Haemophilus pleuropneumoniae.

Authors:  V J Rapp; R S Munson; R F Ross
Journal:  Infect Immun       Date:  1986-05       Impact factor: 3.441

3.  [Haemophilus infection in pigs. 3. Serological studies on Haemophilus parahaemolyticus].

Authors:  J Nicolet
Journal:  Zentralbl Bakteriol Orig       Date:  1971

4.  Serotyping of Haemophilus pleuropneumoniae by rapid slide agglutination and indirect fluorescent antibody tests in swine.

Authors:  V J Rapp; R F Ross; B Z Erickson
Journal:  Am J Vet Res       Date:  1985-01       Impact factor: 1.156

5.  Serological characterization of Haemophilus pleuropneumoniae (Actinobacillus pleuropneumoniae) strains and proposal of a new serotype: serotype 10.

Authors:  R Nielsen
Journal:  Acta Vet Scand       Date:  1985       Impact factor: 1.695

6.  Dot-enzyme immunoassay for visual detection of antibodies to pseudorabies virus in swine serum.

Authors:  A Afshar; P F Wright; G C Dulac
Journal:  J Clin Microbiol       Date:  1986-03       Impact factor: 5.948

7.  Characterization of Haemophilus spp. isolated from healthy swine and evaluation of cross-reactivity of complement-fixing antibodies to Haemophilus pleuropneumoniae and Haemophilus taxon "minor group".

Authors:  V J Rapp; R F Ross; T F Young
Journal:  J Clin Microbiol       Date:  1985-12       Impact factor: 5.948

8.  Purification and partial characterization of the capsular polymer of Haemophilus pleuropneumoniae serotype 5.

Authors:  T J Inzana
Journal:  Infect Immun       Date:  1987-07       Impact factor: 3.441

9.  Isolation and biological characterization of two lipopolysaccharides and a capsular-enriched polysaccharide preparation from Haemophilus pleuropneumoniae.

Authors:  B W Fenwick; B I Osburn; H J Olander
Journal:  Am J Vet Res       Date:  1986-07       Impact factor: 1.156

10.  Composition and antigenic activity of the oligosaccharide moiety of Haemophilus influenzae type b lipooligosaccharide.

Authors:  T J Inzana; W E Seifert; R P Williams
Journal:  Infect Immun       Date:  1985-05       Impact factor: 3.441

View more
  39 in total

1.  The N-terminal domain of RTX toxin ApxI of Actinobacillus pleuropneumoniae elicits protective immunity in mice.

Authors:  J N Seah; J Frey; J Kwang
Journal:  Infect Immun       Date:  2002-11       Impact factor: 3.441

2.  Detection and identification of Actinobacillus pleuropneumoniae serotypes 1, 2, and 8 by multiplex PCR.

Authors:  Jennifer A Schuchert; T J Inzana; Ø Angen; S Jessing
Journal:  J Clin Microbiol       Date:  2004-09       Impact factor: 5.948

3.  Use of an inhibition enzyme-linked immunosorbent assay for quantification of capsular polysaccharide or proteins in vaccines.

Authors:  Thomas J Inzana; Anna Champion
Journal:  Clin Vaccine Immunol       Date:  2007-01-31

4.  Optimization and standardization of an enzyme-linked immunosorbent assay protocol for serodiagnosis of Actinobacillus pleuropneumoniae serotype 5.

Authors:  Y L Trottier; P F Wright; S Larivière
Journal:  J Clin Microbiol       Date:  1992-01       Impact factor: 5.948

5.  Temperature-sensitive mutants of Actinobacillus pleuropneumoniae induce protection in mice.

Authors:  W Byrd; A M Hooke
Journal:  Infect Immun       Date:  1997-06       Impact factor: 3.441

6.  Detection of serotype-specific antibodies or capsular antigen of Actinobacillus pleuropneumoniae by a double-label radioimmunoassay.

Authors:  T J Inzana; G F Clark; J Todd
Journal:  J Clin Microbiol       Date:  1990-02       Impact factor: 5.948

7.  Detection and identification of Actinobacillus pleuropneumoniae serotype 5 by multiplex PCR.

Authors:  T M Lo; C K Ward; T J Inzana
Journal:  J Clin Microbiol       Date:  1998-06       Impact factor: 5.948

8.  Efficacy of a cell extract from Actinobacillus (Haemophilus) pleuropneumoniae serotype 1 against disease in swine.

Authors:  P J Fedorka-Cray; M J Huether; D L Stine; G A Anderson
Journal:  Infect Immun       Date:  1990-02       Impact factor: 3.441

9.  Purification and partial characterization of the capsular polymer of Haemophilus pleuropneumoniae serotype 5.

Authors:  T J Inzana
Journal:  Infect Immun       Date:  1987-07       Impact factor: 3.441

10.  Transposon mutagenesis in Actinobacillus pleuropneumoniae with a Tn10 derivative.

Authors:  R I Tascon; E F Rodriguez-Ferri; C B Gutierrez-Martin; I Rodriguez-Barbosa; P Berche; J A Vazquez-Boland
Journal:  J Bacteriol       Date:  1993-09       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.